Anandita Agarwala
Overview
Explore the profile of Anandita Agarwala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Chambergo-Michilot D, Alur A, Kulkarni S, Agarwala A
Vasc Health Risk Manag
. 2022 Feb;
18:73-80.
PMID: 35221690
Familial hypercholesterolemia (FH) is an autosomal dominant condition that leads to significantly elevated low-density lipoprotein cholesterol (LDL-C) levels and an elevated risk for cardiovascular disease. Mipomersen is an antisense oligonucleotide...
32.
Kianoush S, Al Rifai M, Patel J, George J, Gulati M, Taub P, et al.
Prog Cardiovasc Dis
. 2022 Feb;
71:86-91.
PMID: 35182577
Objectives: To identify whether social vulnerability is associated with low cardiac rehabilitations (CR) use, a Class I recommendation by current treatment guidelines following acute myocardial infarction (AMI). Methods: We performed...
33.
Aggarwal M, Ros E, Allen K, Sikand G, Agarwala A, Aspry K, et al.
Am J Med
. 2022 Feb;
135(6):680-687.
PMID: 35134371
In cardiology clinic visits, the discussion of optimal dietary patterns for prevention and management of cardiovascular disease is usually very limited. Herein, we explore the benefits and risks of various...
34.
Thakkar A, Agarwala A, Michos E
Eur Cardiol
. 2021 Nov;
16:e41.
PMID: 34815749
Cardiovascular disease (CVD) remains the leading cause of death in women globally. Younger women (<55 years of age) who experience MI are less likely to receive guideline-directed medical therapy (GDMT),...
35.
Agarwala A, Goldberg A, Ballantyne C, Guyton J
J Clin Lipidol
. 2021 Nov;
15(4):530-537.
PMID: 34815066
Clinical lipidology belongs par excellence to the preventive mode of medical practice. This Roundtable brings two long-time advocates of cardiometabolic prevention and a newly minted preventive cardiologist into a discussion...
36.
Bekele N, Agarwala A, Wang Z, Goldberg A
J Clin Lipidol
. 2021 Oct;
15(6):793-795.
PMID: 34645588
We describe a case of a 59-year-old man with severe heterozygous familial hypercholesterolemia (FH) and elevated lipoprotein(a) presenting with severe aortic stenosis, treated with transcatheter aortic valve replacement (TAVR). His...
37.
Saeed A, Zhu J, Thoma F, Marroquin O, Aiyer A, Agarwala A, et al.
Circ Cardiovasc Qual Outcomes
. 2021 Aug;
14(9):e007485.
PMID: 34455825
Background: Current American College of Cardiology/American Heart Association guidelines recommend using the 10-year atherosclerotic cardiovascular disease (ASCVD) risk to guide statin therapy for primary prevention. Real-world data on adherence and...
38.
Agarwala A, Bekele N, Deych E, Rich M, Hussain A, Jones L, et al.
J Am Heart Assoc
. 2021 Aug;
10(17):e020890.
PMID: 34431361
Background Black men and women are at higher risk for, and suffer greater morbidity and mortality from, atherosclerotic cardiovascular disease (ASCVD) compared with adults of European Ancestry (EA). Black patients...
39.
Thobani A, Hassen L, Mehta L, Agarwala A
Curr Atheroscler Rep
. 2021 Aug;
23(10):58.
PMID: 34345940
Purpose Of Review: In this review, we discuss strategies for managing dyslipidemia in pregnant women with ASCVD. Recent Findings: Cardiovascular disease (CVD) is the leading cause of mortality in women...
40.
Virani S, Morris P, Agarwala A, Ballantyne C, Birtcher K, Kris-Etherton P, et al.
J Am Coll Cardiol
. 2021 Aug;
78(9):960-993.
PMID: 34332805
No abstract available.